Your browser doesn't support javascript.
loading
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
Mondi, Annalisa; Mastrorosa, Ilaria; Piselli, Pierluca; Cimaglia, Claudia; Matusali, Giulia; Carletti, Fabrizio; Giannico, Giuseppina; Milozzi, Eugenia; Biliotti, Elisa; Di Bari, Silvia; Chinello, Pierangelo; Beccacece, Alessia; Faraglia, Francesca; Vittozzi, Pietro; Mosti, Silvia; Tetaj, Nardi; Stazi, Giulia Valeria; Pinnetti, Carmela; Camici, Marta; D'Annunzio, Alberto; Marani, Alessandra; Fabeni, Lavinia; Specchiarello, Eliana; Gruber, Cesare Ernesto Maria; Villanacci, Alberta; Minicucci, Sabrina; Garbuglia, Anna Rosa; Ianniello, Stefania; Marchioni, Luisa; Taglietti, Fabrizio; D'Offizi, Gianpiero; Palmieri, Fabrizio; Nicastri, Emanuele; Maggi, Fabrizio; Vaia, Francesco; Girardi, Enrico; Antinori, Andrea.
Afiliação
  • Mondi A; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Mastrorosa I; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Piselli P; Department of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Cimaglia C; Department of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Matusali G; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Carletti F; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Giannico G; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Milozzi E; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Biliotti E; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Di Bari S; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Chinello P; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Beccacece A; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Faraglia F; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Vittozzi P; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Mosti S; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Tetaj N; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Stazi GV; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Pinnetti C; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Camici M; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • D'Annunzio A; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Marani A; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Fabeni L; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Specchiarello E; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Gruber CEM; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Villanacci A; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Minicucci S; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Garbuglia AR; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Ianniello S; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Marchioni L; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Taglietti F; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • D'Offizi G; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Palmieri F; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Nicastri E; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Maggi F; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Vaia F; General Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Girardi E; Department of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Antinori A; Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
J Med Virol ; 95(6): e28831, 2023 06.
Article em En | MEDLINE | ID: mdl-37246793

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article